Artificial intelligence (AI) and alternative variables (AV) in drug discovery: A promising alliance.

Journal: Drug discovery today
Published Date:

Abstract

No abstract available for this article.

Authors

  • Celerino Abad-Zapatero
    Institute for Tuberculosis Research, Center for Biomolecular Sciences, Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois Chicago, Chicago, IL, 60607, United States. Electronic address: caz@uic.edu.